Ferritin, Iron Homeostasis and Cellular Stress
铁蛋白、铁稳态和细胞压力
基本信息
- 批准号:6884634
- 负责人:
- 金额:$ 37.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-09-01 至 2006-04-30
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assayantioxidantscellular pathologychemopreventioncytokineferritingene induction /repressiongene targetinggenetic mappinggenetically modified animalshomeostasisimmunoprecipitationiron metabolismlaboratory mousemodel design /developmentmolecular cloningoxidative stressp53 gene /proteinpolymerase chain reactionprotein structure functionsouthern blottingtranscription factoryeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): The metallochemistry and molecular biology
of iron converge in the study of ferritin structure and function. Ferritin is
an iron binding protein whose regulation, once thought to be responsive only to
changes in cellular iron content, has more recently been shown to be targeted
by stress-induced stimuli, including cytokines, oxidants, and a range of
xenobiotics. We now know that agents such as tumor necrosis factor, reactive
oxygen species, and other stimuli trigger ferritin induction; ferritin, in
turn, alters cellular iron homeostasis by sequestering reactive, "low molecular
weight" cellular iron. This in turn reduces susceptibility to subsequent
stress. In this proposal we explore the hypothesis that ferritin regulation is
instrumental in modulating the magnitude and character of the cellular response
to injury and stress. We examine the unique contribution of ferritin to the
phenotype of cells and tissues exposed to prooxidants and antioxidants. In our
first Specific Aim, we explore the molecular mechanisms by which ferritin
participates in the chemopreventive response to prooxidant xenobiotics. In our
second Specific Aim, we explore potential pathways by which oxidative stress
regulates ferritin in health and disease. In our third Specific Aim, we develop
in vivo mouse models to test the relevance of our findings in the context of
whole animals.
描述(由申请人提供):金属化学和分子生物学
铁的研究集中在铁蛋白结构和功能的研究上。铁蛋白是
一种铁结合蛋白,其调节曾被认为只对
细胞铁含量的变化,最近已被证明是针对
应激诱导的刺激,包括细胞因子,氧化剂,和一系列的
异生物质我们现在知道,肿瘤坏死因子、反应性
氧物种和其他刺激触发铁蛋白诱导;铁蛋白,
反过来,通过螯合反应性的“低分子”铁,
重”细胞铁。这反过来又降低了对后续疾病的易感性。
应力在这个建议中,我们探讨了铁蛋白调节是一个假设,
有助于调节细胞反应的幅度和特征
伤害和压力。我们研究了铁蛋白的独特贡献,
暴露于促氧化剂和抗氧化剂的细胞和组织的表型。在我们
第一个具体的目标,我们探索铁蛋白的分子机制,
参与对促氧化剂异生物质的化学预防反应。在我们
第二个具体目标,我们探索氧化应激的潜在途径,
调节健康和疾病中的铁蛋白。在第三个具体目标中,我们开发了
体内小鼠模型,以测试我们的研究结果的相关性,
整个动物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANK M. TORTI其他文献
FRANK M. TORTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANK M. TORTI', 18)}}的其他基金
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
10063489 - 财政年份:2019
- 资助金额:
$ 37.9万 - 项目类别:
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
10529292 - 财政年份:2019
- 资助金额:
$ 37.9万 - 项目类别:
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
9887273 - 财政年份:2019
- 资助金额:
$ 37.9万 - 项目类别:
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
10304862 - 财政年份:2019
- 资助金额:
$ 37.9万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 37.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
- 批准号:
10750132 - 财政年份:2024
- 资助金额:
$ 37.9万 - 项目类别:
Biology the initiator: Harnessing Reactive Oxygen Species for Biocompatible Polymerization
生物学引发者:利用活性氧进行生物相容性聚合
- 批准号:
10667740 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Developing Tools to Understand an Alternative Fate of Urate in Neurodegenerative Diseases
开发工具来了解尿酸盐在神经退行性疾病中的替代命运
- 批准号:
10668103 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Heat therapy for the treatment of SCI-induced changes in nociceptor and mitochondrial function
热疗法治疗 SCI 引起的伤害感受器和线粒体功能变化
- 批准号:
10641385 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Exploring regulatory mechanisms of glyoxalase-1
探索乙二醛酶-1的调控机制
- 批准号:
10646721 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
- 批准号:
10643012 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Combinatorial Neuroprotective Strategies for Preterm Brain Injury
早产儿脑损伤的组合神经保护策略
- 批准号:
10798705 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别: